Literature DB >> 8759769

Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.

B L Sullivan1, E J Knopoff, M Saifuddin, D M Takefman, M N Saarloos, B E Sha, G T Spear.   

Abstract

This study was undertaken to directly assess the susceptibility of HIV-1 plasma virus to C-mediated lysis. Plasma from HIV-infected individuals was collected and ultracentrifuged over 20% sucrose to isolate virions from plasma components including anticoagulants, which inhibit C activity. Treatment with C alone in the absence of exogenously added Ab caused lysis of virus from all patients (n = 18) (range 14 to 86%). This lysis occurred via the classical C pathway and was not due to cross-reactive Abs in the C source. Protein A bound a fraction of isolated plasma virus and this binding was blocked by purified human Ig suggesting that anti-HIV Abs bound to plasma virus could be responsible for inducing C activation. A portion of virus bound to CR2 on cells in the absence of exogenously added C indicating that virus activated C in vivo. C levels from six of six patients were determined to be sufficient to lead to lysis of virus in vivo. Since plasma virus appeared more sensitive to C than primary isolates, isolated virus was evaluated for the presence of C control proteins. While primary isolate virions contained CD46, CD55, and CD59, only CD59 was detected on plasma virus. The results of this study strongly suggest that C is activated by a portion of plasma virus in vivo due to the binding of Ab. The resultant opsonization plus subsequent lysis may be important routes of clearance and destruction of plasma virus in infected persons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759769

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.

Authors:  W S Hlavacek; C Wofsy; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

4.  CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.

Authors:  G G Olinger; M Saifuddin; G T Spear
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components.

Authors:  Dimitry N Krementsov; Patrice Rassam; Emmanuel Margeat; Nathan H Roy; Jürgen Schneider-Schaulies; Pierre-Emmanuel Milhiet; Markus Thali
Journal:  Traffic       Date:  2010-11       Impact factor: 6.215

6.  Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

Authors:  S D Lawn; B D Roberts; G E Griffin; T M Folks; S T Butera
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Authors:  Michael Huber; Viktor von Wyl; Christoph G Ammann; Herbert Kuster; Gabriela Stiegler; Hermann Katinger; Rainer Weber; Marek Fischer; Heribert Stoiber; Huldrych F Günthard; Alexandra Trkola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

Review 8.  The good and evil of complement activation in HIV-1 infection.

Authors:  Qigui Yu; Richard Yu; Xuebin Qin
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

9.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

10.  Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficiency virus type 1.

Authors:  M N Saarloos; B L Sullivan; M A Czerniewski; K D Parameswar; G T Spear
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.